Medicinova (MNOV) Non-Current Debt (2010)
Medicinova (MNOV) posted quarterly Non-Current Debt of $9.5 million for Q4 2010.
Medicinova (MNOV) Non-Current Debt (2010) Analysis & Trends
Medicinova (MNOV) has reported Non-Current Debt for 1 consecutive years, with $9.5 million the latest figure, recorded in Q4 2010.
- In Q4 2010, Non-Current Debt changed N/A year-over-year to $9.5 million; the TTM figure through Dec 2010 stood at $9.5 million (changed N/A YoY), while the FY2010 annual figure was $9.5 million, changed N/A from the prior year.
- Non-Current Debt steadied at $9.5 million in Q4 2010 per MNOV's latest filing.
- Across five years, Non-Current Debt topped out at $9.5 million in Q4 2010 and bottomed at $9.5 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 9.48 Mn |